| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 08/17/2006 | WO2006086343A2 Chemical exchange saturation transfer based mri using reporter genes and mri methods related thereto |
| 08/17/2006 | WO2006086159A2 Method for monitoring early treatment response |
| 08/17/2006 | WO2006085941A1 Copper-complex isonitrile positron emission tomography (pet) imaging agent and method |
| 08/17/2006 | WO2006085908A2 Devices and methods for measuring and enhancing drug or analyte transport to/from medical implant |
| 08/17/2006 | WO2006084382A1 Compositions and methods for multimodal imaging |
| 08/17/2006 | WO2005096811A3 In vivo bioassay for gonadotropins |
| 08/17/2006 | WO2005089813A3 Receptor-avid exogenous optical contrast and therapeutic agents |
| 08/17/2006 | WO2005059517A3 Toll-like receptor assays |
| 08/17/2006 | WO2004094647A3 Methods of treating diseases responsive to induction of apoptosis and screening assays |
| 08/17/2006 | WO2003088904A3 Screening and therapeutic methods for treating circadian rhythm disorders |
| 08/17/2006 | WO2003087124A3 Hmgn2 peptides and related melecules that selectively home to tumor blood vessels and tumor cells |
| 08/17/2006 | US20060184074 Solid hydrogel coupling for ultrasound imaging and therapy |
| 08/17/2006 | US20060182688 Metronidazole-based tinted topical pharmaceutical compositions |
| 08/17/2006 | US20060182687 Conjugates for dual imaging and radiochemotherapy: composition, manufacturing, and applications |
| 08/17/2006 | US20060182686 kainate receptor agonists; immunoassay; measuring bioavailability, pharmacokinetics via onset of seizures |
| 08/17/2006 | US20060182685 Hollow fiber technique for in vivo study of cell populations |
| 08/17/2006 | CA2596595A1 Compositions and methods for multimodal imaging |
| 08/17/2006 | CA2595526A1 Colonic delivery of active agents |
| 08/17/2006 | CA2569375A1 Devices and methods for measuring and enhancing drug or analyte transport to/from medical implant |
| 08/16/2006 | EP1690546A2 Transplants for myocardial scars and method and cellular preparations therefor |
| 08/16/2006 | EP1689442A2 Composition comprising antibodies and methods of using the same for targeted nanoparticulate active agent delivery |
| 08/16/2006 | EP1689439A2 Small molecule compositions and methods for increasing drug efficiency using compositions thereof |
| 08/16/2006 | EP1689365A1 Drug delivery vehicles and uses thereof |
| 08/16/2006 | EP1330659B1 Method and device for dissolving hyperpolarised solid material for nmr analyses |
| 08/16/2006 | EP1289569B1 Diagnosing colic type in an infant |
| 08/16/2006 | EP1272225B1 Lipid-based systems for targeting diagnostic agents |
| 08/16/2006 | EP1094799B1 Apomorphine-containing dosage forms for ameliorating male erectile dysfunction |
| 08/16/2006 | EP0836484B1 In vitro packaging of adeno-associated virus dna |
| 08/16/2006 | CN1820200A Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 08/16/2006 | CN1820025A Fluorescein-labelled peptides |
| 08/16/2006 | CN1819847A Vitronectin receptor antagonist compounds and their use in the preparation of diopharmaceuticals |
| 08/16/2006 | CN1818650A Single-wall carbon nanometer tube tracer with fluorescent label DNA, its production and use |
| 08/16/2006 | CN1818641A Fast inspection of transgenic cotton against pests |
| 08/16/2006 | CN1817324A Dynamic inhalational contamination experimental instrument with solid-phase dust |
| 08/16/2006 | CN1269531C Light-stabilized in vivo stain composition and method of manufacture |
| 08/16/2006 | CN1269530C Antibody-dye conjugates for binding to target structures of angiogenesis in order to introperatively depict tumor peripheries |
| 08/15/2006 | US7091310 Chemokine analogs for the treatment of human disease |
| 08/15/2006 | US7091260 Bone cement mixture and x-ray contrast medium as well as method for their preparation |
| 08/15/2006 | US7090829 Antitumor agnets; anticancer agents; antidiabetic agents |
| 08/15/2006 | US7090828 Vitronectin receptor antagonist pharmaceuticals |
| 08/15/2006 | CA2263102C Compositions comprising microparticles of water-insoluble substances and method for preparing same |
| 08/10/2006 | WO2006084257A2 Steady state perfusion methods |
| 08/10/2006 | WO2006083293A1 Method for characterizing the oxidative stress protective capacity of an antioxidative substance |
| 08/10/2006 | WO2005092073A3 Use of anti-alpha5beta1 antibodies to inhibit cancer cell proliferation |
| 08/10/2006 | WO2005024440A3 Polarizing agents for dynamic nuclear polarization |
| 08/10/2006 | US20060179501 Transgenic mice expressing human cd20 |
| 08/10/2006 | US20060179492 Method of inhibiting neural transmission mediated by serotonin-2a and enhancing sensorimotor gating |
| 08/10/2006 | US20060178314 Methods and compositions for treating atheroma, tumors and other neoplastic tissues |
| 08/10/2006 | US20060178295 androgen steroid conjugated with one or more mammalian proteins; diagnosis or treatment of solid cancer and hematological malignancies; exhibit a synergistic action together with a cytoskeleton-acting drug such as Taxol (reg); prostate cancer |
| 08/10/2006 | US20060177457 Are designed to produce both Type 1 and Type 2 phototherapeutic effect at once using dual wavelength light source that will produce singlet oxygen and free radicals at the lesion of interest; for dual phototherapy of tumors and other lesions |
| 08/10/2006 | US20060177381 Opiopathies |
| 08/10/2006 | US20060177380 Methods and compositions for deterring abuse of orally administered pharmaceutical products |
| 08/10/2006 | US20060177379 Composition comprising an agent providing a signal, an implant material and a drug |
| 08/10/2006 | US20060177378 Measuring amount of Choline present in tissue adjoining or surrounding cancerous tissue before and after treatment by Magnetic Resonance Spectroscopy (MRS), after administration of angiogenesis inhibitor |
| 08/10/2006 | US20060177377 Measuring amount of Choline present in tissue adjoining or surrounding cancerous tissue before and after treatment by Magnetic Resonance Spectroscopy (MRS), after administration of angiogenesis inhibitor |
| 08/10/2006 | US20060177375 In a population of subjects with the defect, measuring a change in the presence of lung infection in subjects who have been administered the agent in comparison those who have not; the agents tested lack intrinsic antibiotic activity |
| 08/10/2006 | DE102005005704A1 Partikel zur Ermittlung der lokalen Temperatur in organischen und nichtorganischen Körpern Particles for determining the local temperature in organic and inorganic bodies |
| 08/10/2006 | CA2596863A1 Steady state perfusion methods |
| 08/09/2006 | EP1687441A1 Means and methods for the determination of camp in vitro and in vivo |
| 08/09/2006 | EP1687035A1 Method for high-throughput screening of compounds and combinations of compounds for discovery and quantification of actions, particularly unanticipated therapeutic or toxic actions, in biological systems |
| 08/09/2006 | EP1687034A1 Contrast agent for medical imaging techniques and usage thereof |
| 08/09/2006 | EP1687024A2 Carbohydrate antigen-nanoparticle conjugates and uses thereof as antimetastatic agents in treating cancer |
| 08/09/2006 | EP1531871B1 Method and apparatus for producing contrast agents for magnetic resonance imaging |
| 08/09/2006 | EP1372741B1 Morpholino imaging and therapy |
| 08/09/2006 | EP1265546A4 Methods and apparatus for optical imaging |
| 08/09/2006 | EP1133319B1 Photosensitizer conjugates for targeting intracellular pathogens |
| 08/09/2006 | CN1814611A Ligand compound for image diagnosis and its preparing method and compound for image diagnosis and its intermediate preparation |
| 08/09/2006 | CN1814307A Skeleton tablet core for digestive tract evacuation-detecting slow-release tablet and its preparing process |
| 08/09/2006 | CN1814306A Digestive tract evacuation-detecting slow-release tablet and its preparing process |
| 08/09/2006 | CN1814305A Gene-ordrug-carrying-carrying ultrasonic microvesicle contrast-media and preparing method thereof |
| 08/09/2006 | CN1814304A Biotechnological treating method of biomass for stomach intestine contrast-media |
| 08/09/2006 | CN1814287A Prevention and treatment of amyloidogenic disease |
| 08/09/2006 | CN1268397C Method for enhancing echogenicity and decreasing attenuation of microencapsulated gases |
| 08/08/2006 | US7087724 Carrier molecules |
| 08/08/2006 | US7087722 Fibrin binding domain polypeptides and uses and methods of producing same |
| 08/08/2006 | US7087229 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 08/08/2006 | US7087213 Method of preparing cow brain homogenate |
| 08/08/2006 | US7087212 Multilayer binding; lamellar surface structure |
| 08/08/2006 | CA2193503C Butylene oxide-ethylene oxide block copolymer surfactants as stabilizer coatings for nanocrystal formulation |
| 08/03/2006 | WO2006081521A2 Methods for diagnosis and intervention of hepatic disorders |
| 08/03/2006 | WO2006081396A2 Compositions and methods for delivery of agents into cells |
| 08/03/2006 | WO2006081323A2 Anti-cancer dna vaccine employing plasmids encoding mutant oncoprotein antigen and calreticulin |
| 08/03/2006 | WO2006080243A1 Coated magnetic particle containing preparation, process for producing the same and diagnostic therapeutic system |
| 08/03/2006 | WO2006080024A2 Device, system and method for in vivo analysis |
| 08/03/2006 | WO2006080022A2 Mri contrast agents for diagnosis and prognosis of tumors |
| 08/03/2006 | WO2006066104A3 Stilbene derivatives and their use for binding and imaging amyloid plaques |
| 08/03/2006 | WO2006060332A3 Electroporation of mycobacterium and overexpression of antigens in mycobacteria |
| 08/03/2006 | WO2006056227A8 Conjugates comprising the active agent and flanking or branched-chain peptides |
| 08/03/2006 | WO2006032911A3 Metalloproteinase inhibitor imaging agents |
| 08/03/2006 | WO2005072710A3 Drugs and gene carrier particles that rapidly move through mucous barriers |
| 08/03/2006 | US20060172960 cellular senescence and immortalization; administering a telemerase inhibitor; reduced loss of telomere length; antiproliferative agents |
| 08/03/2006 | US20060172943 Restoring vascular function |
| 08/03/2006 | US20060172358 Novel chemiluminescent compounds and their use |
| 08/03/2006 | US20060171895 Medical imaging reference devices |
| 08/03/2006 | US20060171894 Pharmaceutical preparation containing magnetic vesicular particles, manufacturing method thereof and diagnostic therapeutic system |
| 08/03/2006 | US20060171893 Antineoplastic agents targeted via glut transporters |
| 08/03/2006 | US20060171892 Conjugates for medical imaging comprising carrier, targetting moiety and a contrast agent |
| 08/03/2006 | US20060171890 Methods for evaluating the activity of candidate agents |
| 08/03/2006 | US20060171889 Irrigating fluid |
| 08/03/2006 | US20060171888 Miniaturized device; substrate with reservoirs, openings; barriers layer covering aperture |